IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q1 2022 Holdings

Filed 2022-05-16 | 20 holdings | $352.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vaxcyte(PCVX)Common92243G108$100.5K4,168,71828.5%
Vera(VERA)Common92337R101$69.3K2,960,23119.7%
Adicet(TORCEUR)Common007002108$42.2K2,115,38512.0%
Sierra OncologyCommon82640U107$42.1K1,314,01211.9%
JasperCommon471871103$19.5K5,628,5585.5%
Phathom(PHAT)Common71722W107$19.5K1,435,1065.5%
eFFECTORCommon28202V108$18.9K4,822,1145.4%
Verona(VRNA)SPONDS ADR925050106$12.1K2,457,4993.4%
Reneo(RPHM)Common75974E103$6.1K2,073,9571.7%
SientraCommon82621J105$5.2K2,349,8271.5%
SolenoCommon834203200$4.0K18,022,6021.1%
Spruce BioCommonE5209E109$3.6K1,792,5181.0%
NucanaADR67022C106$3.3K3,333,3330.9%
ParatekCommon699374302$3.1K1,041,1310.9%
Exicure(XCUR)Common30205M101$1.4K6,977,0000.4%
Molecular TemplatesCommon608550109$690200,0000.2%
Aeglea(AGLEUSD)Common00773J103$553240,5000.2%
Cymabay(CBAYUSD)Common23257D103$406131,0360.1%
ObsevaCommonH5861P103$13387,9990.0%
OcugenCommon43358V109$237,1110.0%